ZBNA
ALNY icon

Zions Bancorporation, National Association’s Alnylam Pharmaceuticals ALNY Stock Holding History

Zions Bancorporation, National Association’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Sell
1,159
-2,481
-68% -$748K 0.02% 302
2026
Q1 		$1.2M Buy
3,640
+3,493
+2,376% +$1.19M 0.08% 143
2025
Q4 		$58.5K Buy
147
+138
+1,533% +$61.1K ﹤0.01% 576
2025
Q3 		$4.1K Sell
9
-637
-99% -$259K ﹤0.01% 758
2025
Q2 		$211K Hold
646
– – 0.01% 338
2025
Q1 		$174K Buy
+646
New +$166K 0.01% 339

Other funds holding ALNY

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Zions Bancorporation, National Association's ALNY Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Alnylam Pharmaceuticals (ALNY) stake by 68% in Q2 2026, selling an estimated $748K and leaving 1,159 shares worth $349K. The position accounts for 0.02% of the portfolio, ranked #302.

Zions Bancorporation, National Association first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.2M in Q1 2026. 306 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Zions Bancorporation, National Association held 1,159 shares of Alnylam Pharmaceuticals worth $349K as of Q2 2026.
  • Zions Bancorporation, National Association sold 2,481 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $748K.
  • Alnylam Pharmaceuticals made up 0.02% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #302 holding.
  • Zions Bancorporation, National Association first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Alnylam Pharmaceuticals position peaked at $1.2M in Q1 2026.
  • 306 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.